Condition: Epilepsy; Seizure · Child Development · Gene Abnormality · Sponsor: Number 2 Children's Hospital, Ho Chi Minh City
According to estimates by the World Health Organization in 2019, more than 50 million people around the world have epilepsy. Nearly 80% of patients with epilepsy live in developing countries. Among them, children under 2 years old are the group with the highest incidence of epilepsy, and at the same time, the most dangerous epilepsy groups are also likely to start at these ages. World medical literature on epileptic encephalopathy and early-onset development before 2 years of age records that 71% of children have severe intellectual disability and 60% of children show signs of autism spectrum disorder, of which Children with epileptic and developmental encephalopathy due to genetic causes are at higher risk of developing neurodevelopmental disorders than children with epileptic and developmental encephalopathy due to other causes. However, in Vietnam, there is no research on this topic. The question is what are the phenotypes, genotypes, and progression after 2 years of follow-up of Vietnamese children with epileptic and developmental encephalopathy with onset before 2 years of age?
This description comes directly from the study's public registry record.
Thuy-Minh-Thu Thuy Minh NGUYEN, MD · +84983966371 · dr.thu.nguyen.neurology@gmail.com
Always discuss trial participation with your own doctor first.
| Children hospital number 2 | Ho Chi Minh City, Vietnam | Recruiting |
| University of Medicine and Pharmacy at Ho Chi Minh city | Ho Chi Minh City, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06278428